Insider buying last 90 days
No open-market insider purchases were filed for DK in the last 90 days.
From Form 4 filings, dated to when each was filed.
Delek US shares have gained 48.3% over six months, with strength attributed to favorable refining conditions and strategic initiatives across its four refineries. The main headline this week concerns a $400 million private offering of convertible senior notes due 2031, with proceeds earmarked for capped call transactions to reduce dilution and to partially repay a term loan; the announcement was followed by a 4.9% drop in the stock price as investors weighed potential dilution concerns.
DK closed at $67.47, down 0.5%, sitting between its 50-day average of $69.08 and 200-day average of $47.69. The GekkoIndex reading of 66.8 places the stock in the Accumulation zone. Price sits 5.6% below Gekko Fair Value of $71.45.
The next earnings date falls on 6 November 2026, 38 days out and beyond a typical 20-trading-day window; the prior report showed EPS of $5.48 against an estimate of $2.21, though the stock reacted with an 11.3% move. In the last 30 days, 2 unusual options signals were recorded, with call premium of $704,700 against put premium of $739,800. Seasonality over the next 20 trading days has averaged a 5.8% return across 5 years, rising in 3 of them. Analyst consensus stands at 5 buy, 4 hold, and 1 sell ratings, with a consensus target of $75.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Delek US scores 4 supportive, 1 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed1 headwind
Averages disagree
Close $67.47 sits between the 50-day ($69.08) and 200-day ($47.69) averages, or the averages disagree.
See the chart66.8, Accumulation
Reading 66.8 is in the Accumulation zone.
See the GekkoIndex5.6% below
Price is 5.6% below Gekko Fair Value (more than 5% below).
See fair valueLeans bearish
Last 30 days: 2 unusual options signals.
See smart moneyReports in 38 days
Next report Nov 6, 2026, 38 days away — outside a typical 20-trading-day hold.
See earnings+5.8% on average
From this point in the calendar, the next 20 trading days averaged +5.8% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Delek US closed at $67.47 on Sep 28, 2026, +100.9% over the past year, inside a 52-week range of $25.85 to $82.27.
Use the left and right arrow keys to read daily values.
Put DK on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Delek US turns crude oil into everyday fuels and products for the American market, running a business built around refining, moving, and selling petroleum. It processes raw crude into gasoline, diesel, jet fuel, and asphalt at four refineries in Texas, Arkansas, and Louisiana, supported by three biodiesel plants, and it is also recognized for its network of convenience stores selling fuel and merchandise across West Texas and New Mexico.
The company works through three connected segments. Refining converts crude into finished fuels distributed through its own and outside facilities. Logistics moves and stores crude oil and refined products using pipelines, a gathering network, storage tanks, and distribution terminals, while also marketing fuel for outside parties. Retail runs hundreds of convenience stores under the DK, Alon, and 7-Eleven names, offering fuel alongside food, beverages, tobacco, and general goods. Its customers range from major oil companies and independent refiners to distributors, transportation firms, government buyers, and retail fuel operators.
Delek US was founded in 2001 and is headquartered in Brentwood, Tennessee. Its shares trade on the NYSE under the ticker DK.
Delek US’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 66.8, in the Accumulation zone, up 12.7 points over five sessions.
Up 12.7 points over five sessions, from the Neutral zone.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 71 | +1.7% | +1.6% | ||
| Accumulation (current zone) | 192 | +0.5% | +6.5% | ||
| Neutral | 332 | +1.4% | +4.8% | ||
| Distribution | 73 | +0.9% | +1.3% | ||
| Selling | 4 | Too few readings yet | |||
Average DK share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Delek US trades 5.6% below Gekko Fair Value of $71.45, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Delek US shares are worth, recalculated every trading day.
$71.45
Gekko Fair Value, Sep 29, 2026
5.6% Undervalued
No open-market insider purchases were filed for Delek US, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for DK in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in DK were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Delek US has been buying back its own shares.
From company filings.
2signals, 49% of the flagged premium in calls.
Latest: Bullish flow on Sep 16, $705K in unusual premium.
1of the funds Gekko tracks holds DK.
Delek US reports on Nov 6, 2026 (38 days away), and beat the EPS estimate in 8 of its last 8 reports.
Nov 6, 2026
38 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $5.48 est $2.21 | $4.09B est $3.44B | −11.3% |
| Apr 29, 2026 | $0.08 est −$1.61 | $2.65B est $2.33B | +13.5% |
| Feb 27, 2026 | $0.44 est −$0.19 | $2.43B est $2.55B | +13.6% |
| Nov 7, 2025 | $1.52 est $0.28 | $2.89B est $2.55B | +5.8% |
| Aug 6, 2025 | −$0.56 est −$0.92 | $2.76B est $2.69B | −1.6% |
| May 7, 2025 | −$2.32 est −$2.43 | $2.64B est $2.76B | +8.8% |
| Feb 25, 2025 | −$2.54 est −$2.82 | $2.37B est $2.69B | −7.7% |
| Nov 6, 2024 | −$1.45 est −$1.61 | $3.04B est $2.48B | +10.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Delek US is $75.00, +11.2% from the last close, from 10 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 10 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 14 | TD Cowen | $90 | +33.4% |
| Sep 14 | Raymond James | $90 | +33.4% |
| Sep 14 | Morgan Stanley | $81 | +20.1% |
| Sep 10 | Bank of America Securities | $58 | −14.0% |
| Sep 1 | Wells Fargo | $82 | +21.5% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 26, Delek US averaged +5.8% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.6% | 1 of 5 |
| Next 10 trading days | +3.5% | 3 of 5 |
| Next 15 trading days | +2.7% | 3 of 5 |
| Next 20 trading days | +5.8% | 3 of 5 |
| Next 30 trading days | +8.4% | 2 of 5 |
For scale, DK’s typical 20-trading-day move in either direction is about 10%.
Delek US’s market cap is $4.14B, with a P/E ratio of 18.5 and revenue of $12.06B over the last twelve months.
Coverage of Delek US this week reads neutral: 2 positive, 4 neutral and 2 negative headlines.
Delek US’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MPCMarathon Petroleum | Neutral | 1.3% above |
| VLOValero Energy | Neutral | 15.3% above |
| PSXPhillips 66 | Neutral | 14.4% above |
| DINOHF Sinclair | Neutral | 22.3% above |
| PBFPBF Energy | Neutral | 3.4% below |
| CVICVR Energy | Neutral | 57.8% above |
A peer links to its own page where one exists.
Delek US’s market cap is $4.14B at the Sep 28, 2026 close of $67.47, with 61.23M shares outstanding. The shares trade on a P/E ratio of 18.5.
The consensus analyst 12-month price target for Delek US is $75.00, +11.2% from the last close. Of the 10 firms that rated the stock in the last 90 days, 5 rate it a buy, 4 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Delek US is undervalued: the Sep 28, 2026 close of $67.47 is 5.6% below Gekko Fair Value of $71.45. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Delek US is expected to report on Nov 6, 2026 (38 days away). Analysts expect earnings of $6.31 per share on revenue of $3.55B. Delek US beat the earnings estimate in 8 of its last 8 reports, moving 9.1% on average across the report.
Delek US’s 52-week high is $82.27 and its 52-week low is $25.85; it closed at $67.47 on Sep 28, 2026, +100.9% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend) and 1 as a headwind (smart money). The checklist is a description of current data, not a recommendation.
Gekko flagged 2 unusual options signals in Delek US over the last 30 days, with $705K of flagged premium in calls and $740K in puts. The latest, bullish flow, was on Sep 16, 2026 with $705K in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.